| Dr Kevin M Kitagawa, MD | |
|
417 State St, Suite 439, Bangor, ME 04401-6635 | |
| (207) 941-8200 | |
| (207) 990-4848 |
| Full Name | Dr Kevin M Kitagawa |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 23 Years |
| Location | 417 State St, Bangor, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538363171 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4754 (Hawaii) | Secondary |
| 174400000X | Specialist | MD19249 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cary Medical Center | Caribou, ME | Hospital |
| Redington Fairview General Hospital | Skowhegan, ME | Hospital |
| St Joseph Hospital | Bangor, ME | Hospital |
| St Mary's Regional Medical Center | Lewiston, ME | Hospital |
| Eastern Maine Medical Center | Bangor, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dahl Chase Pathology Associates Pa | 8820995947 | 15 |
News Archive
New findings from the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
Each day, 80 people are newly diagnosed with Parkinson's disease (PD) in the UK and one in 20 will be under the age of 40.
Dr. Robert Zura, the Robert D'Ambrosia Professor and Head of Orthopaedic Surgery at LSU Health New Orleans School of Medicine, was part of a research team that identified risk factors which may help orthopaedic surgeons better predict a serious complication of bone fractures.
New research at West Virginia University is examining whether a smokeless, spitless tobacco product aimed at young adults is catching on.
› Verified 2 days ago
| Entity Name | Dahl Chase Pathology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992726913 PECOS PAC ID: 8820995947 Enrollment ID: O20031217000381 |
News Archive
New findings from the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
Each day, 80 people are newly diagnosed with Parkinson's disease (PD) in the UK and one in 20 will be under the age of 40.
Dr. Robert Zura, the Robert D'Ambrosia Professor and Head of Orthopaedic Surgery at LSU Health New Orleans School of Medicine, was part of a research team that identified risk factors which may help orthopaedic surgeons better predict a serious complication of bone fractures.
New research at West Virginia University is examining whether a smokeless, spitless tobacco product aimed at young adults is catching on.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin M Kitagawa, MD 417 State St, Suite 439, Bangor, ME 04401-6635 Ph: (207) 941-8200 | Dr Kevin M Kitagawa, MD 417 State St, Suite 439, Bangor, ME 04401-6635 Ph: (207) 941-8200 |
News Archive
New findings from the St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project (PCGP) have helped identify the mechanism that makes the childhood eye tumor retinoblastoma so aggressive. The discovery explains why the tumor develops so rapidly while other cancers can take years or even decades to form.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
Each day, 80 people are newly diagnosed with Parkinson's disease (PD) in the UK and one in 20 will be under the age of 40.
Dr. Robert Zura, the Robert D'Ambrosia Professor and Head of Orthopaedic Surgery at LSU Health New Orleans School of Medicine, was part of a research team that identified risk factors which may help orthopaedic surgeons better predict a serious complication of bone fractures.
New research at West Virginia University is examining whether a smokeless, spitless tobacco product aimed at young adults is catching on.
› Verified 2 days ago